PREVENTION OF RECURRENT CLOSTRIDIOIDES DIFFICILE INFECTION AT TWO YEARS AFTER TREATMENT WITH INVESTIGATIONAL MICROBIOTA-BASED DRUG RBX2660: EFFICACY, DURABILITY, MICROBIOME CHANGES, AND PARTICIPANT DEMOGRAPHICS OF A PHASE 2 OPEN-LABEL CLINICAL TRIAL

Christina Reimer  1     Robert Orenstein  2     Lindy Bancke  3     Carlos Gonzalez  4     Ken Blount  4    
1 Ferring Pharmaceuticals A/S, Copenhagen, Denmark
2 Mayo Clinic in Arizona, Phoenix, United States
3 Rebiotix Inc., Roseville, United States
4 BioRankings, LLC, St. Louis, United States

Session
Other lower GI disorders (Posters)

Conference
UEG Week Virtual 2020

Citation
United European Gastroenterology Journal 2020; 8 (Supplement 1)

Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing